Switch to:
Also traded in: UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.31
CSRMY's Cash to Debt is ranked lower than
81% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. CSRMY: 0.31 )
Ranked among companies with meaningful Cash to Debt only.
CSRMY' s Cash to Debt Range Over the Past 10 Years
Min: 0.18  Med: 0.90 Max: 18483
Current: 0.31
0.18
18483
Equity to Asset 0.43
CSRMY's Equity to Asset is ranked lower than
78% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. CSRMY: 0.43 )
Ranked among companies with meaningful Equity to Asset only.
CSRMY' s Equity to Asset Range Over the Past 10 Years
Min: 0.43  Med: 0.61 Max: 0.83
Current: 0.43
0.43
0.83
Interest Coverage 3.94
CSRMY's Interest Coverage is ranked lower than
94% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 481.81 vs. CSRMY: 3.94 )
Ranked among companies with meaningful Interest Coverage only.
CSRMY' s Interest Coverage Range Over the Past 10 Years
Min: 3.52  Med: 8.44 Max: 19.19
Current: 3.94
3.52
19.19
F-Score: 5
Z-Score: 1.53
WACC vs ROIC
0.49%
4.73%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) 4.42
CSRMY's Operating margin (%) is ranked higher than
54% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.89 vs. CSRMY: 4.42 )
Ranked among companies with meaningful Operating margin (%) only.
CSRMY' s Operating margin (%) Range Over the Past 10 Years
Min: 4.42  Med: 12.99 Max: 17.83
Current: 4.42
4.42
17.83
Net-margin (%) 2.68
CSRMY's Net-margin (%) is ranked higher than
54% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. CSRMY: 2.68 )
Ranked among companies with meaningful Net-margin (%) only.
CSRMY' s Net-margin (%) Range Over the Past 10 Years
Min: 1.98  Med: 7.79 Max: 25.45
Current: 2.68
1.98
25.45
ROE (%) 3.10
CSRMY's ROE (%) is ranked higher than
52% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. CSRMY: 3.10 )
Ranked among companies with meaningful ROE (%) only.
CSRMY' s ROE (%) Range Over the Past 10 Years
Min: 3.1  Med: 12.53 Max: 24.93
Current: 3.1
3.1
24.93
ROA (%) 1.61
CSRMY's ROA (%) is ranked higher than
55% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: -0.07 vs. CSRMY: 1.61 )
Ranked among companies with meaningful ROA (%) only.
CSRMY' s ROA (%) Range Over the Past 10 Years
Min: 1.61  Med: 6.38 Max: 14.87
Current: 1.61
1.61
14.87
ROC (Joel Greenblatt) (%) 6.80
CSRMY's ROC (Joel Greenblatt) (%) is ranked higher than
54% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. CSRMY: 6.80 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CSRMY' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 6.8  Med: 27.39 Max: 31.64
Current: 6.8
6.8
31.64
Revenue Growth (3Y)(%) 10.50
CSRMY's Revenue Growth (3Y)(%) is ranked higher than
76% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. CSRMY: 10.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CSRMY' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -13  Med: 0.40 Max: 16.5
Current: 10.5
-13
16.5
EBITDA Growth (3Y)(%) -16.00
CSRMY's EBITDA Growth (3Y)(%) is ranked lower than
77% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. CSRMY: -16.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CSRMY' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -17.9  Med: 0.40 Max: 23.5
Current: -16
-17.9
23.5
EPS Growth (3Y)(%) -27.80
CSRMY's EPS Growth (3Y)(%) is ranked lower than
84% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. CSRMY: -27.80 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CSRMY' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -40.8  Med: 2.30 Max: 57.1
Current: -27.8
-40.8
57.1
» CSRMY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with CSRMY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 83.30
CSRMY's P/E(ttm) is ranked lower than
89% of the 250 Companies
in the Global Medical Devices industry.

( Industry Median: 27.86 vs. CSRMY: 83.30 )
Ranked among companies with meaningful P/E(ttm) only.
CSRMY' s P/E(ttm) Range Over the Past 10 Years
Min: 8.02  Med: 14.99 Max: 96.25
Current: 83.3
8.02
96.25
Forward P/E 18.05
CSRMY's Forward P/E is ranked higher than
59% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 18.66 vs. CSRMY: 18.05 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 66.20
CSRMY's PE(NRI) is ranked lower than
84% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 28.10 vs. CSRMY: 66.20 )
Ranked among companies with meaningful PE(NRI) only.
CSRMY' s PE(NRI) Range Over the Past 10 Years
Min: 11.06  Med: 16.59 Max: 76.49
Current: 66.2
11.06
76.49
P/B 2.44
CSRMY's P/B is ranked higher than
55% of the 385 Companies
in the Global Medical Devices industry.

( Industry Median: 2.63 vs. CSRMY: 2.44 )
Ranked among companies with meaningful P/B only.
CSRMY' s P/B Range Over the Past 10 Years
Min: 1.27  Med: 2.28 Max: 3.48
Current: 2.44
1.27
3.48
P/S 1.92
CSRMY's P/S is ranked higher than
60% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 2.24 vs. CSRMY: 1.92 )
Ranked among companies with meaningful P/S only.
CSRMY' s P/S Range Over the Past 10 Years
Min: 0.65  Med: 1.56 Max: 3.03
Current: 1.92
0.65
3.03
POCF 34.48
CSRMY's POCF is ranked lower than
72% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 19.65 vs. CSRMY: 34.48 )
Ranked among companies with meaningful POCF only.
CSRMY' s POCF Range Over the Past 10 Years
Min: 4.71  Med: 10.47 Max: 55.08
Current: 34.48
4.71
55.08
EV-to-EBIT 77.35
CSRMY's EV-to-EBIT is ranked lower than
89% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 24.07 vs. CSRMY: 77.35 )
Ranked among companies with meaningful EV-to-EBIT only.
CSRMY' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.7  Med: 12.50 Max: 77.35
Current: 77.35
7.7
77.35
EV-to-EBITDA 26.02
CSRMY's EV-to-EBITDA is ranked lower than
71% of the 285 Companies
in the Global Medical Devices industry.

( Industry Median: 17.52 vs. CSRMY: 26.02 )
Ranked among companies with meaningful EV-to-EBITDA only.
CSRMY' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.7  Med: 8.00 Max: 26.02
Current: 26.02
4.7
26.02
Shiller P/E 27.00
CSRMY's Shiller P/E is ranked higher than
67% of the 64 Companies
in the Global Medical Devices industry.

( Industry Median: 32.91 vs. CSRMY: 27.00 )
Ranked among companies with meaningful Shiller P/E only.
CSRMY' s Shiller P/E Range Over the Past 10 Years
Min: 10.41  Med: 21.03 Max: 31.22
Current: 27
10.41
31.22
Current Ratio 0.64
CSRMY's Current Ratio is ranked lower than
95% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.66 vs. CSRMY: 0.64 )
Ranked among companies with meaningful Current Ratio only.
CSRMY' s Current Ratio Range Over the Past 10 Years
Min: 0.64  Med: 1.33 Max: 3.58
Current: 0.64
0.64
3.58
Quick Ratio 0.50
CSRMY's Quick Ratio is ranked lower than
94% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. CSRMY: 0.50 )
Ranked among companies with meaningful Quick Ratio only.
CSRMY' s Quick Ratio Range Over the Past 10 Years
Min: 0.5  Med: 1.07 Max: 3.01
Current: 0.5
0.5
3.01
Days Inventory 163.59
CSRMY's Days Inventory is ranked lower than
58% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 142.23 vs. CSRMY: 163.59 )
Ranked among companies with meaningful Days Inventory only.
CSRMY' s Days Inventory Range Over the Past 10 Years
Min: 163.59  Med: 176.39 Max: 212.47
Current: 163.59
163.59
212.47
Days Sales Outstanding 95.30
CSRMY's Days Sales Outstanding is ranked lower than
68% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 72.25 vs. CSRMY: 95.30 )
Ranked among companies with meaningful Days Sales Outstanding only.
CSRMY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 37.49  Med: 43.82 Max: 95.3
Current: 95.3
37.49
95.3
Days Payable 190.13
CSRMY's Days Payable is ranked higher than
87% of the 256 Companies
in the Global Medical Devices industry.

( Industry Median: 59.85 vs. CSRMY: 190.13 )
Ranked among companies with meaningful Days Payable only.
CSRMY' s Days Payable Range Over the Past 10 Years
Min: 91.73  Med: 128.99 Max: 190.13
Current: 190.13
91.73
190.13

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.86
CSRMY's Dividend Yield is ranked higher than
59% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.72 vs. CSRMY: 1.86 )
Ranked among companies with meaningful Dividend Yield only.
CSRMY' s Dividend Yield Range Over the Past 10 Years
Min: 1.57  Med: 3.17 Max: 5.74
Current: 1.86
1.57
5.74
Dividend Payout 1.83
CSRMY's Dividend Payout is ranked lower than
98% of the 122 Companies
in the Global Medical Devices industry.

( Industry Median: 0.34 vs. CSRMY: 1.83 )
Ranked among companies with meaningful Dividend Payout only.
CSRMY' s Dividend Payout Range Over the Past 10 Years
Min: 0.22  Med: 0.49 Max: 1.97
Current: 1.83
0.22
1.97
Dividend Growth (3y) -0.90
CSRMY's Dividend Growth (3y) is ranked lower than
56% of the 64 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. CSRMY: -0.90 )
Ranked among companies with meaningful Dividend Growth (3y) only.
CSRMY' s Dividend Growth (3y) Range Over the Past 10 Years
Min: -0.9  Med: 1.30 Max: 9.1
Current: -0.9
-0.9
9.1
Forward Dividend Yield 1.31
CSRMY's Forward Dividend Yield is ranked lower than
62% of the 176 Companies
in the Global Medical Devices industry.

( Industry Median: 1.76 vs. CSRMY: 1.31 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 2.00
CSRMY's Yield on cost (5-Year) is ranked higher than
53% of the 189 Companies
in the Global Medical Devices industry.

( Industry Median: 1.87 vs. CSRMY: 2.00 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
CSRMY' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 1.69  Med: 3.41 Max: 6.18
Current: 2
1.69
6.18
3-Year Average Share Buyback Ratio -11.90
CSRMY's 3-Year Average Share Buyback Ratio is ranked lower than
71% of the 194 Companies
in the Global Medical Devices industry.

( Industry Median: -4.30 vs. CSRMY: -11.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CSRMY' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -11.9  Med: -0.80 Max: -0.1
Current: -11.9
-11.9
-0.1

Valuation & Return

vs
industry
vs
history
Earnings Yield (Greenblatt) (%) 1.30
CSRMY's Earnings Yield (Greenblatt) (%) is ranked higher than
54% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.70 vs. CSRMY: 1.30 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CSRMY' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 1.3  Med: 8.00 Max: 13
Current: 1.3
1.3
13
Forward Rate of Return (Yacktman) (%) -4.55
CSRMY's Forward Rate of Return (Yacktman) (%) is ranked lower than
69% of the 108 Companies
in the Global Medical Devices industry.

( Industry Median: 5.28 vs. CSRMY: -4.55 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CSRMY' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -11.9  Med: 8.60 Max: 14.2
Current: -4.55
-11.9
14.2

More Statistics

Revenue(Mil) $280
EPS $ 0.18
Beta0.49
Short Percentage of Float0.00%
52-Week Range $12.90 - 15.75
Shares Outstanding(Mil)49.13

Analyst Estimate

Apr16 Apr17 Apr18
Revenue(Mil) 375 397 410
EPS($) 0.79 0.88 0.98
EPS without NRI($) 0.79 0.88 0.98

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Traded in other countries:CSRT.UK,
Consort Medical PLC was incorporated on March 22, 1946. The Company is engaged in the design, development and manufacture of specialty medical drug delivery devices and services to the pharmaceutical industry through Bespak and the supply of active pharmaceutical ingredient and finished dose formulation and manufacturing services through Aesica. Its products include metered dose inhalers, dry powder devices, actuators, dose counters, disposable auto-injectors, nasal devices and point-of-care diagnostics devices.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK